Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL29 Protein (AA 21-200, partial) (His-SUMO Tag)

IL29 Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant > 90 % SDS
N° du produit ABIN5711509
  • Antigène Voir toutes IL29 Protéines
    IL29 (Interleukin 29 (IL29))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 21-200, partial
    Origine
    • 18
    • 1
    • 1
    Humain
    Source
    • 10
    • 6
    • 1
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette IL29 protéine est marqué à la His-SUMO Tag.
    Application
    SDS-PAGE (SDS)
    Séquence
    VPTSKPTTTG KGCHIGRFKS LSPQELASFK KARDALEESL KLKNWSCSSP VFPGNWDLRL LQVRERPVAL EAELALTLKV LEAAAGPALE DVLDQPLHTL HHILSQLQAC IQPQPTAGPR PRGRLHHWLH RLQEAPKKES AGCLEASVTF NLFRLLTRDL KYVADGNLCL RTSTHPEST-
    Purification
    SDS-PAGE
    Pureté
    > 90 %
    Top Product
    Discover our top product IL29 Protéine
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.1-2 mg/mL
    Buffer
    20 mM Tris-HCl based buffer, pH 8.0
    Stock
    -80 °C,4 °C,-20 °C
    Stockage commentaire
    Store at -20°C, for extended storage, conserve at -20°C or -80°C. Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
  • Antigène
    IL29 (Interleukin 29 (IL29))
    Autre désignation
    IFNL1 (IL29 Produits)
    Synonymes
    IL-29 Protein, IL29 Protein, interferon lambda 1 Protein, interferon lambda-1 Protein, interleukin 29 (interferon, lambda 1) Protein, IFNL1 Protein, LOC612539 Protein, IL29 Protein
    Sujet
    Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagent leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression.
    Poids moléculaire
    35.85 kDa
    UniProt
    Q8IU54
Vous êtes ici:
Support technique